| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
134,859
|
135,264
|
128,487
|
138,847
| | Cost of Revenue | 61,879 | 64,096 | 56,899 | 63,091 | | |
Gross Profit
|
72,980
|
71,168
|
71,588
|
75,756
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 63,026 | 64,249 | 62,656 | 63,252 |
|
Non Recurring | 272 | 462 | 333 | 653 |
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
9,682
|
6,457
|
8,599
|
11,851
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
| (9) |
-
| (12) |
|
Earnings Before Interest And Taxes | 9,682 | 6,448 | 8,599 | 11,839 |
|
Interest Expense | 127 | 200 | 161 | 310 |
|
Income Before Tax | 9,555 | 6,248 | 8,438 | 11,529 |
|
Income Tax Expense | 3,678 | 2,406 | 3,249 | 4,588 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 5,877 | 3,833 | 5,189 | 6,929 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
5,877
|
3,842
|
5,189
|
6,941
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
5,877
|
3,842
|
5,189
|
6,941
|
|
0.01(0.04%) 2:27PM EDT - Nasdaq Real Time Price